This speculative review of potential medical applications of LLMs completely ignores two of the largest risks - model hallucinations and premature clinical deployment by credulous hospital administrators of unverified and unverifiable systems trained on proprietary datasets by unscrupulous vendors. https://www.nature.com/articles/s41586-023-05881-4
Follow
Even more troubling is the fact that Eric Topol, one of the corresponding authors on the paper, didn't declare any competing interests for the paper when he's a scientific advisor for a AI based precision medicine company.
